Clinical antiangiogenic effect of recombinant adenovirus-p53 combined with hyperthermia for advanced cancer

Chinese Journal of Cancer Research

Volumn 25, Issue 6, 2013, Pages 749-755

  Li, Xiaofan ^a   Xiao, Shaowen ^a   Li, Yongheng ^a   Zhang, Shanwen ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Advanced cancer; Hyperthermia; Radiotherapy; Recombinant adenovirus p53 (rAd p53); Vascular epithelial growth factor (VEGF)

Indexed keywords

GENDICINE; PROTEIN P53; VASCULOTROPIN;

ADENOID CYSTIC CARCINOMA; ADENOVIRUS; ADULT; ADVANCED CANCER; AGED; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; INJECTION SITE DISCOMFORT; INJECTION SITE PAIN; KARNOFSKY PERFORMANCE STATUS; LARYNX SQUAMOUS CELL CARCINOMA; LIPOSARCOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT NEURILEMOMA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; OBSERVATIONAL STUDY; ONCOLYTIC VIROTHERAPY; PRIMARY TUMOR; PROTEIN EXPRESSION; RADIATION DOSE; SOFT TISSUE SARCOMA; SQUAMOUS CELL CARCINOMA; THYROID CARCINOMA; TREATMENT FAILURE; TREATMENT RESPONSE; UPREGULATION; VIRAL GENE THERAPY; VIRUS PARTICLE; VIRUS RECOMBINANT;

EID: 84901436800     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.3978/j.issn.1000-9604.2013.12.05     Document Type: Article

References (23)

1. Zhang SW, Xiao WQ, Lu YY. Role of p53 tumor suppresspr gene in radiosensitivity of human gastric carcinoma cell lines. Zhong Hua Fang She Zhong Liu Xue Za Zhi (in Chinese) 1999;8:116-9.
2. Zhang SW, Xiao WQ, Lu YY. Enhancement effect of the tumor suppressor p53 gene on thermosensitivity on human gastric cancer cell lines. Zhong Hua Wu Li Yi Xue Yu Kang Fu Za Zhi (in Chinese) 2000;22:94-6
3. Zhang SW, Xiao SW, Lu YY. Effect of adenovirus-mediated p53 gene transfer on apoptosis and radiosensitivity of human gastric carcinoma cell lines. Chin J Cancer Res 2003;1:14-8.
4. Zhang SW, Xiao SW, Lu YY. Adenovirus-mediated p53 gene transfer increases the thermosensitivity of human gastric carcinoma cell lines (in vitro and in vivo). Chin J Cancer Res 2003;15:107-11.
5. Pan JJ, Zhang SW, Chen CB, et al. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma. J Clin Oncol 2009;27:799-804.
6. Fujiwara T, Nishizaki M, Tanaka N. Recombinant adenovirus expressing wild-type p53 is antiagiogenic: Implication for lung cancer gene therapy. Gan To Kagaku Ryoho 2000;27:1217-24.
7. Zhang L, Yu D, Hu M, et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res 2000;60:3655-61. (Pubitemid 30482190)
8. Nishizaki M, Fujiwara T, Tanida T, et al. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: A proposed mechanism for by-stander effect. Clin Cancer Res 1999;5:1015-23. (Pubitemid 29233215)
9. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205-16. (Pubitemid 30099779)
10. Hiraoka M, Akuta K, Nishimura Y, et al. Tumor response to thermoradiation therapy: use of CT in evaluation. Radiology 1987;164:259-62. (Pubitemid 17089916)
11. Takeshita N, Tanaka Y, Matsuda T. Evaluation of CT images, tumor response and prognosis after thermoradiotherapy for deep-seated tumors. Int J Hyperthermia 1993;9:1-17. (Pubitemid 23052363)
12. Choi H, Charnsangavej C, de Castro Faria S, et al. CT Evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 2004;183:1619-28. (Pubitemid 44210530)
13. Clayman GL, el-Naggar AK, Lippman SM, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol 1998;16:2221-32. (Pubitemid 28265061)
14. Clayman GL, Frank DK, Bruso PA, et al. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers. Clin Cancer Res 1999;5:1715-22. (Pubitemid 29334451)
15. Shimada H, Matsubara H, Shiratori T, et al. Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. Cancer Sci 2006;97:554-61. (Pubitemid 43811599)
16. Schuler M, Rochlitz C, Horowitz JA, et al. A phase I study of adenovirus -mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum Gene Ther 1998;9:2075-82. (Pubitemid 28463925)
17. Swisher SG, Roth JA, Komaki R, et al. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 2003;9:93-101. (Pubitemid 36109720)
18. Wen SF, Mahavni V, Quijano E, et al. Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer. Cancer Gene Ther 2003;10:224-38. (Pubitemid 36348684)
19. Kuball J, Wen SF, Leissner J, et al. Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation. J Clin Oncol 2002;20:957-65. (Pubitemid 34141838)
20. Zhang S, Xu G, Liu C, et al. Clinical study of recombinant adenovirus-p53 (Adp53) combined with hyperthermia in advanced cancer (a report of 15 cases). Int J Hyperthermia 2005;21:631-6. (Pubitemid 41684237)
21. Teodoro JG, Evans SK, Green MR. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med (Berl) 2007;85:1175-86. (Pubitemid 47622219)
22. Sano M, Minamino T, Toko H, et al. p53-induced inhibition of Hif-1 cause scardiac dysfunction during pressure overload. Nature 2007;446:444-8. (Pubitemid 46474597)
23. Dai F, Chen Y, Song Y, et al. A natural small molecule harmine inhibits angiogenesis and suppresses tumor growth through activation of p53 in endothelial cells. PLoS One 2012;7:e52162.